Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer

Clinical Breast Cancer

Volumn 13, Issue 6, 2013, Pages 433-438

  Campagnoli, Carlo ^a   Berrino, Franco ^b   Venturelli, Elisabetta ^b   Abbà, Chiara ^a   Biglia, Nicoletta ^c   Brucato, Tiziana ^a   Cogliati, Patrizia ^b   Danese, Saverio ^a   Donadio, Michela ^d   Zito, Gianna ^a   Pasanisi, Patrizia ^b  

^a Ospedale sant'Anna   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

Dehydroepiandrosterone sulfate; Estradiol; IGF1; Randomized trial; Testosterone

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; INSULIN; METFORMIN; PRASTERONE SULFATE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ANDROSTENEDIONE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; BODY MASS; BREAST CANCER; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

DEHYDROEPIANDROSTERONE SULFATE; ESTRADIOL; IGF1; RANDOMIZED TRIAL; TESTOSTERONE;

AGED; ANDROGENS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIABETES MELLITUS; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; PROGNOSIS;

EID: 84889066710     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.08.012     Document Type: Article

References (59)

1. N.F. Col, L. Ochs, and V. Springmann Metformin and breast cancer risk: a meta-analysis and critical literature review Breast Cancer Res Treat 135 2012 639 646
2. R.T. Chlebowski, A. McTiernan, and J. Wactawski-Wende Diabetes, metformin, and breast cancer in postmenopausal women J Clin Oncol 30 2012 2844 2852
3. S. Bayraktar, L.F. Hernadez-Aya, and X. Lei Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer Cancer 118 2012 1202 1211
4. S. Jiralerspong, S.L. Palla, and S.H. Giordano Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 2009 3297 3302
5. + breast cancer Ann Oncol 23 2012 1771 1780
6. R.J. Dowling, S. Niraula, and V. Stambolic Metformin in cancer: translational challenges J Mol Endocrinol 48 2012 R31 R43
7. F.J. Esteva, S.L. Moulder, and A.M. Gonzalez-Angulo Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer Cancer Chemother Pharmacol 71 2013 63 72
8. P.J. Goodwin, V. Stambolic, and J. Lemieux Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents Breast Cancer Res Treat 126 2011 215 220
9. M. Pollak Metformin and other biguanides in oncology: advancing the research agenda Cancer Prev Res (Phila) 3 2010 1060 1065
10. D.H. Cohen, and D. LeRoith Obesity, type 2 diabetes, and cancer: the insulin and IGF connection Endocr Relat Cancer 19 2012 F27 F45
11. C. Duggan, M.L. Irwin, and L. Xiao Associations of insulin resistance and adiponectin with mortality in women with breast cancer J Clin Oncol 29 2011 32 39
12. P.J. Goodwin, M. Ennis, and K.I. Pritchard Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study J Clin Oncol 20 2002 42 51
13. M.J. Gunter, D.R. Hoover, and H. Yu Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women J Natl Cancer Inst 101 2009 48 60
14. S. Sieri, P. Muti, and C. Agnoli Prospective study on the role of glucose metabolism in breast cancer occurrence Int J Cancer 130 2012 921 929
15. A. Belfiore, F. Frasca, and G. Pandini Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease Endocr Rev 30 2009 586 623
16. F. Berrino, P. Pasanisi, and C. Bellati Serum testosterone levels and breast cancer recurrence Int J Cancer 113 2005 499 502
17. J.A. Emond, R.E. Patterson, and L. Natarajan Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes Cancer Epidemiol Biomarkers Prev 20 2011 939 945
18. G.N. Farhat, S.R. Cummings, and R.T. Chlebowski Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers J Natl Cancer Inst 103 2011 562 570
19. S.E. Hankinson, and A.H. Eliassen Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk J Steroid Biochem Mol Biol 106 2007 24 30
20. R.E. James, A. Lukanova, and L. Dossus Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study Cancer Prev Res (Phila) 4 2011 1626 1635
21. T.J. Key, P.N. Appleby, and G.K. Reeves Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies Br J Cancer 105 2011 709 722
22. A. Micheli, E. Meneghini, and G. Secreto Plasma testosterone and prognosis of postmenopausal breast cancer patients J Clin Oncol 25 2007 2685 2690
23. C.L. Rock, S.W. Flatt, and G.A. Laughlin Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer Cancer Epidemiol Biomarkers Prev 17 2008 614 620
24. C. Campagnoli, P. Pasanisi, and C. Abba Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study Clin Breast Cancer 12 2012 175 182
25. S.M. Patel, N. Iqbal, and S. Kaul Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial Fertil Steril 94 2010 2161 2166
26. K.N. Danforth, A.H. Eliassen, and S.S. Tworoger The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women Int J Cancer 126 2010 199 207
27. R.H. Fogle, F.Z. Stanczyk, and X. Zhang Ovarian androgen production in postmenopausal women J Clin Endocrinol Metab 92 2007 3040 3043
28. F. Labrie, C. Martel, and J. Balser Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary? Menopause 18 2011 30 43
29. K. Blouin, M. Nadeau, and J. Mailloux Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis Am J Physiol Endocrinol Metab 296 2009 E244 E255
30. A. Purohit, L.W. Woo, and B.V. Potter Steroid sulfatase: a pivotal player in estrogen synthesis and metabolism Mol Cell Endocrinol 340 2011 154 160
31. T.J. Key Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women Steroids 76 2011 812 815
32. P.E. Lonning, B.P. Haynes, and A.H. Straume Recent data on intratumor estrogens in breast cancer Steroids 76 2011 786 791
33. S.S. Tworoger, B.A. Rosner, and W.C. Willett The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study Breast Cancer Res 13 2011 R99
34. P. Pasanisi, A. Villarini, and E. Bruno Nutritional advice to breast cancer survivors Support Care Cancer 18 suppl 2 2010 S29 S33
35. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
36. L. Dalla Valle, V. Toffolo, and A. Nardi Tissue-specific transcriptional initiation and activity of steroid sulfatase complementing dehydroepiandrosterone sulfate uptake and intracrine steroid activations in human adipose tissue J Endocrinol 190 2006 129 139
37. G.R. Attia, W.E. Rainey, and B.R. Carr Metformin directly inhibits androgen production in human thecal cells Fertil Steril 76 2001 517 524
38. R. Mansfield, R. Galea, and M. Brincat Metformin has direct effects on human ovarian steroidogenesis Fertil Steril 79 2003 956 962
39. S. Palomba, A. Falbo, and F. Zullo Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review Endocr Rev 30 2009 1 50
40. M.A. Maturana, and P.M. Spritzer Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women Metabolism 51 2002 238 243
41. E. Carmina Ovarian and adrenal hyperandrogenism Ann N Y Acad Sci 1092 2006 130 137
42. A. Lanzone, A.M. Fulghesu, and M. Guido Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: relationship with insulin secretion Fertil Steril 58 1992 296 301
43. M. Barba, H.J. Schunemann, and F. Sperati The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis Clin Endocrinol (Oxf) 70 2009 661 670
44. C. Kim, S. Kong, and G.A. Laughlin Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program J Clin Endocrinol Metab 97 2012 2853 2861
45. J.P. Garay, and B.H. Park Androgen receptor as a targeted therapy for breast cancer Am J Cancer Res 2 2012 434 445
46. T.E. Hickey, J.L. Robinson, and J.S. Carroll Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Mol Endocrinol 26 2012 1252 1267
47. A. Naderi, K.M. Chia, and J. Liu Synergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer Breast Cancer Res 13 2011 R36
48. M. Ni, Y. Chen, and E. Lim Targeting androgen receptor in estrogen receptor-negative breast cancer Cancer Cell 20 2011 119 131
49. C. Dimitrakakis, and C. Bondy Androgens and the breast Breast Cancer Res 11 2009 212
50. L.F. Macedo, Z. Guo, and S.L. Tilghman Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole Cancer Res 66 2006 7775 7782
51. E.F. Need, L.A. Selth, and T.J. Harris Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor alpha in luminal breast cancer cells Mol Endocrinol 26 2012 1941 1952
52. K. Takagi, Y. Miki, and S. Nagasaki Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment Endocr Relat Cancer 17 2010 415 430
53. K.A. Brown, N.U. Samarajeewa, and E.R. Simpson Endocrine-related cancers and the role of AMPK Mol Cell Endocrinol 366 2013 170 179
54. S. Rice, L. Pellatt, and K. Ramanathan Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway Endocrinology 150 2009 4794 4801
55. A.K. Dunbier, H. Anderson, and Z. Ghazoui Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women J Clin Oncol 28 2010 1161 1167
56. N. Honma, S. Saji, and M. Hirose Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol Cancer Sci 102 2011 1848 1854
57. I. Castellano, E. Allia, and V. Accortanzo Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers Breast Cancer Res Treat 124 2010 607 617
58. S. Park, J.S. Koo, and M.S. Kim Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers Ann Oncol 22 2011 1755 1762
59. C. Campagnoli, P. Pasanisi, and I. Castellano Postmenopausal breast cancer, androgens, and aromatase inhibitors Breast Cancer Res Treat 139 2013 1 11